Free tool
FAERS Monitor: Parsabiv
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 208325 or its brand name (Parsabiv, Etelcalcetide). Reports on generic versions are filed under their own applications.
Reports
2,877
Serious
1,403
49% of reports
Hospitalization
815
Death reported
335
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- underdose247
- shunt stenosis204
- nausea192
- hypocalcaemia151
- product storage error149
- blood parathyroid hormone increased145
- shunt occlusion128
- blood calcium decreased124
- diarrhoea116
- vomiting107
- circumstance or information capable of leading to medication error82
- death82
- drug ineffective76
- fall74
- cardiac failure66
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2016 | 2 |
| 2017 | 212 |
| 2018 | 918 |
| 2019 | 628 |
| 2020 | 378 |
| 2021 | 251 |
| 2022 | 208 |
| 2023 | 128 |
| 2024 | 81 |
| 2025 | 56 |
| 2026 | 15 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,282 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| shunt stenosisSignal | 204 | 20447.8 | 15690.7 | 1,093,832 |
| shunt occlusionSignal | 128 | 2464.7 | 2024.1 | 233,965 |
| blood parathyroid hormone increasedSignal | 145 | 383.0 | 325.4 | 52,146 |
| blood calcium decreasedSignal | 124 | 81.5 | 68.5 | 9,677 |
| hypocalcaemiaSignal | 151 | 58.8 | 50.3 | 8,459 |
| underdoseSignal | 247 | 24.8 | 22.0 | 5,623 |
| circumstance or information capable of leading to medication errorSignal | 82 | 17.8 | 14.4 | 1,282 |
| product storage errorSignal | 149 | 12.5 | 10.7 | 1,563 |
| cardiac failureSignal | 66 | 6.0 | 4.7 | 272 |
| nausea | 192 | 1.8 | 1.5 | 67 |
| vomiting | 107 | 1.7 | 1.4 | 28 |
| fall | 74 | 1.6 | 1.3 | 17 |
| diarrhoea | 116 | 1.3 | 1.1 | 9 |
| death | 82 | 0.7 | 0.6 | 11 |
| drug ineffective | 76 | 0.4 | 0.3 | 64 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.